ClinicalTrials.gov
public full text
Public Domain
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
anatomic-stage-i-breast-cancer-ajcc-v8anatomic-stage-ii-breast-cancer-ajcc-v8anatomic-stage-iii-breast-cancer-ajcc-v8
This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer#1320071
- Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)#910867
- Extended Endocrine Therapy for Premenopausal Women With Breast Cancer#1394787
- Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer#1164933
- Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer#1114569
Record · ID 1440006
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive